Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study

Prema P. Peethambaram, Tanya L. Hoskin, Courtney N. Day, Matthew P. Goetz, Elizabeth B. Habermann, Judy C. Boughey

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study'. Together they form a unique fingerprint.

Medicine & Life Sciences